Foreign Firms Dominate Over 80 Percent Of Upscale Device Market In China
This article was originally published in PharmAsia News
Multinational companies dominate over 80 percent of the upscale medical device market in China: MNCs comprise 70 percent of the hospital market; seven places among the country's top 10 device companies in revenue; and more than half of the top 50 device companies in total sales and profits, said industry expert Qiu Guixing
You may also be interested in...
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
Janet Woodcock’s 2019 prediction that record ANDA approval volumes would not continue is confirmed with the FY 2020 approval total down 21% from the previous year.
Deal snapshot: Resolving a loose end from its 2014 buyout of Auxilium, Endo acquires all rights to Xiaflex, along with approved cellulite therapy Qwo.